Johnson & Johnson ordered to pay teen $92m
Johnson & Johnson has been ordered to pay $92 million in damages to a teenage boy who developed gynecomastia after taking the antipsychotic drug risperidone.
The court heard the 18-year-old developed size 46DD breasts after taking the drug since the age of five.
The jury found that Johnson & Johnson’s pharmaceutical division, Janssen Pharmaceuticals, knew that the risperidone carried a risk of gynecomastia in men and boys but had “intentionally falsified, destroyed or concealed records” to hide the link.
According to a BMJ report, the company has paid more than $2.8bn to US federal and state governments in 2013 to resolve criminal and civil charges of illegally promoting risperidone for unapproved uses, including for dementia in elderly patients in nursing homes and ADHD in children.
More than 1600 cases are pending in